DECN Stock Overview
Develops smart phone based electronic medical record (EMR) technologies. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Decision Diagnostics Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | -99.94% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| DECN | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 0% | 8.9% | 1.2% |
| 1Y | 0% | 8.7% | 21.0% |
Return vs Industry: DECN underperformed the US Healthcare Services industry which returned 8.7% over the past year.
Return vs Market: DECN underperformed the US Market which returned 21% over the past year.
Price Volatility
| DECN volatility | |
|---|---|
| DECN Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 10.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 18.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine DECN's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | n/a | Keith Berman | www.decisiondiagnostics.co |
Decision Diagnostics Corp. develops smart phone based electronic medical record (EMR) technologies. The company offers prescription and non-prescription diagnostics; home testing products for the chronically ill; fulfillment services to direct to patient diabetes programs; and cell phone centric e-health products and technologies development services. It manufactures and distributes GenUltimate!
Decision Diagnostics Corp. Fundamentals Summary
| DECN fundamental statistics | |
|---|---|
| Market cap | US$380.00 |
| Earnings (TTM) | -US$8.29m |
| Revenue (TTM) | US$2.13m |
0.0x
P/S Ratio0.0x
P/E RatioIs DECN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DECN income statement (TTM) | |
|---|---|
| Revenue | US$2.13m |
| Cost of Revenue | US$1.67m |
| Gross Profit | US$462.23k |
| Other Expenses | US$8.75m |
| Earnings | -US$8.29m |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did DECN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/11 21:30 |
| End of Day Share Price | 2025/02/06 00:00 |
| Earnings | 2021/09/30 |
| Annual Earnings | 2020/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Decision Diagnostics Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.